Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Melbourne Theranostic Innovation Centre

Clinical trials sponsored by Melbourne Theranostic Innovation Centre, explained in plain language.

First human test for new prostate cancer imaging agent

Diagnosis Completed

This study is testing a new imaging agent called 68Ga-NTA-476 for PET scans in men with prostate cancer. It's the first time this agent is being used in people. The main goals are to see where the agent travels in the body after injection, how it compares to the current standard …

Phase: EARLY_PHASE1 • Sponsor: Melbourne Theranostic Innovation Centre • Aim: Diagnosis

Last updated Mar 31, 2026 12:12 UTC